Aldeyra Therapeutics, Inc. (ALDX)
0.6239
-0.01
(-1.55%)
USD |
NASDAQ |
Nov 09, 16:00
0.6239
0.00 (0.00%)
After-Hours: 17:58
Aldeyra Therapeutics Gross Profit (Annual) : -0.252M for Dec. 31, 2025
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -0.252M |
| December 31, 2024 | -0.2496M |
| December 31, 2023 | -0.2628M |
| December 31, 2022 | -0.2587M |
| December 31, 2021 | -0.2642M |
| December 31, 2020 | -0.0562M |
| December 31, 2019 | -0.0963M |
| December 31, 2018 | -0.071M |
| Date | Value |
|---|---|
| December 31, 2017 | -0.0378M |
| December 31, 2016 | -0.0358M |
| December 31, 2015 | -0.0188M |
| December 31, 2014 | -0.0011M |
| December 31, 2013 | 0.00 |
| December 31, 2012 | -0.0037M |
| December 31, 2011 | -0.0016M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Prime Medicine, Inc. | -2.689M |
| Arrowhead Pharmaceuticals, Inc. | 805.52M |
| Oncolytics Biotech, Inc. | -0.07M |
| Sangamo Therapeutics, Inc. | 31.95M |
| Sarepta Therapeutics, Inc. | 1.314B |